Tomé Najdovski
-
- Neuropeptides and Animal Physiology 4
-
- Peptidase Inhibition and Analysis 6
-
- Blood transfusion and management 3
-
- Trauma, Hemostasis, Coagulopathy, Resuscitation 3
-
- Diabetes Treatment and Management 4
-
- Blood donation and transfusion practices 4
-
- Blood properties and coagulation 3
-
- Erythrocyte Function and Pathophysiology 2
- Co-authors
- M Deschodt-LanckmanR. DimalineThierry AppelboomA. MichelFrédéric PeyrussonTiep Khac NguyenFrançoise Van BambekeStanislas Pauwels
- Partner nations
- BelgiumUnited KingdomFrance
In The Last Decade
Tomé Najdovski
19 papers receiving 315 citations
Peers
Comparison fields: 5 of 73
- Cellular and Molecular Neuroscience 98
- Oncology 124
- Biochemistry 20
- Critical Care and Intensive Care Medicine 13
- Cardiology and Cardiovascular Medicine 53
Countries citing papers authored by Tomé Najdovski
This map shows the geographic impact of Tomé Najdovski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomé Najdovski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomé Najdovski more than expected).
Fields of papers citing papers by Tomé Najdovski
This network shows the impact of papers produced by Tomé Najdovski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomé Najdovski. The network helps show where Tomé Najdovski may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tomé Najdovski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 8 | |
| 4 | 2022 | 11 | |
| 5 | 2022 | 42 | |
| 6 | 2021 | 0 | |
| 7 | 2021 | 2 | |
| 8 | 2020 | 10 | |
| 9 | 2018 | 3 | |
| 10 | 2017 | 9 | |
| 11 | 2015 | 1 | |
| 12 | 2014 | 6 | |
| 13 | 2014 | 5 | |
| 14 | Acute toxicity of anti-CD3 monoclonal antibody in mice: a model for OKT3 first dose reactions. | 1990 | 11 |
| 15 | 1989 | 14 | |
| 16 | 1988 | 82 | |
| 17 | 1988 | 30 | |
| 18 | 1988 | 61 | |
| 19 | 1987 | 1 | |
| 20 | 1985 | 21 |
About Tomé Najdovski
Tomé Najdovski is a scholar working on Critical Care and Intensive Care Medicine, Management of Technology and Innovation and Biochemistry, having authored 20 papers that have together received 320 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (6 papers), Diabetes Treatment and Management (4 papers), Neuropeptides and Animal Physiology (4 papers), Blood donation and transfusion practices (4 papers), Blood properties and coagulation (3 papers), Blood transfusion and management (3 papers), Trauma, Hemostasis, Coagulopathy, Resuscitation (3 papers) and Erythrocyte Function and Pathophysiology (2 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (98 citations), Oncology (124 citations) and Biochemistry (20 citations). Tomé Najdovski has collaborated with scholars based in Belgium, United Kingdom and France. Frequent co-authors include M Deschodt-Lanckman, R. Dimaline, Thierry Appelboom, A. Michel, Frédéric Peyrusson, Tiep Khac Nguyen, Françoise Van Bambeke, Stanislas Pauwels, Nadia Collette and G.J. Dockray. Their work appears in journals such as The Journal of Immunology, Gastroenterology and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.